Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Revealed
India's Third Giant Leap

This Could be One of the Biggest Opportunities for Investors




Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD

CARE RATING 2023-24 Annual Report Analysis
Tue, 18 Jun

CARE RATING has announced its results for the year ended March 2024. Let us have a look at the detailed performance review of the company during FY23-24.

CARE RATING Income Statement Analysis

  • Operating income during the year rose 18.9% on a year-on-year (YoY) basis.
  • The company's operating profit increased by 12.9% YoY during the fiscal. Operating profit margins witnessed a fall and stood at 33.8% in FY24 as against 35.6% in FY23.
  • Depreciation charges decreased by 0.4% and finance costs increased by 70.9% YoY, respectively.
  • Other income grew by 23.1% YoY.
  • Net profit for the year grew by 20.0% YoY.
  • Net profit margins during the year grew from 30.6% in FY23 to 30.9% in FY24.

CARE RATING Income Statement 2023-24

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Net Sales Rs m 2,790 3,317 18.9%
Other income Rs m 379 467 23.1%
Total Revenues Rs m 3,169 3,784 19.4%
Gross profit Rs m 993 1,121 12.9%
Depreciation Rs m 105 105 -0.4%
Interest Rs m 10 17 70.9%
Profit before tax Rs m 1,257 1,466 16.6%
Tax Rs m 403 441 9.4%
Profit after tax Rs m 855 1,026 20.0%
Gross profit margin % 35.6 33.8
Effective tax rate % 32.0 30.1
Net profit margin % 30.6 30.9
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Must See: These Segments are Witnessing Incredible Growth with Modi's Push

CARE RATING Balance Sheet Analysis

  • The company's current liabilities during FY24 stood at Rs 787 million as compared to Rs 578 million in FY23, thereby witnessing an increase of 36.1%.
  • Current assets rose 12% and stood at Rs 7 billion, while fixed assets fell 0% and stood at Rs 2 billion in FY24.
  • Overall, the total assets and liabilities for FY24 stood at Rs 8 billion as against Rs 8 billion during FY23, thereby witnessing a growth of 9%.

CARE RATING Balance Sheet as on March 2024

No. of Mths Year Ending 12 Mar-23* 12 Mar-24* % Change
Networth Rs m 6,658 7,120 7.0
 
Current Liabilities Rs m 578 787 36.1
Long-term Debt Rs m 0 0 0.0
Total Liabilities Rs m 7,696 8,418 9.4
 
Current assets Rs m 6,018 6,745 12.1
Fixed Assets Rs m 1,678 1,672 -0.4
Total Assets Rs m 7,696 8,418 9.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



CARE RATING Cash Flow Statement Analysis

  • CARE RATING's cash flow from operating activities (CFO) during FY24 stood at Rs 909 million, an improvement of 10.5% on a YoY basis.
  • Cash flow from investing activities (CFI) during FY24 stood at Rs -391 million on a YoY basis.
  • Cash flow from financial activities (CFF) during FY24 stood at Rs -630 million, an improvement of 1% on a YoY basis.
  • Overall, net cash flows for the company during FY24 stood at Rs -111 million from the Rs 318 million net cash flows seen during FY23.

CARE RATING Cash Flow Statement 2023-24

Particulars No. of months 12 12 % Change
Year Ending Mar-23 Mar-24
Cash Flow from Operating Activities Rs m 822 909 10.5%
Cash Flow from Investing Activities Rs m 129 -391 -
Cash Flow from Financing Activities Rs m -633 -630 -
Net Cash Flow Rs m 318 -111 -
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Current Valuations for CARE RATING

  • The trailing twelve-month earnings per share (EPS) of the company stands at Rs 34.4, an improvement from the EPS of Rs 28.8 recorded last year.
  • The price to earnings (P/E) ratio, at the current price of Rs 1,094.0, stands at 31.9 times its trailing twelve months earnings.
  • The price to book value (P/BV) ratio at current price levels stands at 4.6 times, while the price to sales ratio stands at 9.8 times.
  • The company's price to cash flow (P/CF) ratio stood at 25.0 times its end-of-year operating cash flow earnings.

Per Share Data/Valuations

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Sales per share (Unadj.) Rs 93.9 111.1
TTM Earnings per share Rs 28.8 34.4
Diluted earnings per share Rs 28.6 34.3
Price to Cash Flow x 20.0 25.0
TTM P/E ratio x 22.5 31.9
Price / Book Value ratio x 2.5 4.0
Market Cap Rs m 16,346 28,222
Dividends per share (Unadj.) Rs 25.0 18.0
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



Ratio Analysis for CARE RATING

  • Solvency Ratios
  • Current Ratio: The company's current ratio deteriorated and stood at 8.6x during FY24, from 10.4x during FY23. The current ratio measures the company's ability to pay short-term and long-term obligations.

    Interest Coverage Ratio: The company's interest coverage ratio deteriorated and stood at 86.6x during FY24, from 126.5x during FY23. The interest coverage ratio of a company states how easily a company can pay its interest expense on outstanding debt. A higher ratio is preferable.

  • Profitability Ratios
  • Return on Equity (ROE): The ROE for the company improved and stood at 14.4% during FY24, from 12.8% during FY24. The ROE measures the ability of a firm to generate profits from its shareholders capital in the company.

    Return on Capital Employed (ROCE): The ROCE for the company improved and stood at 20.8% during FY24, from 19.0% during FY23. The ROCE measures the ability of a firm to generate profits from its total capital (shareholder capital plus debt capital) employed in the company.

    Return on Assets (ROA): The ROA of the company improved and stood at 12.4% during FY24, from 11.2% during FY23. The ROA measures how efficiently the company uses its assets to generate earnings.

Key Ratio Analysis

No. of Mths Year Ending 12 Mar-23* 12 Mar-24*
Current ratio x 10.4 8.6
Debtors’ Days Days 267 247
Interest coverage x 126.5 86.6
Debt to equity ratio x 0.0 0.0
Return on assets % 11.2 12.4
Return on equity % 12.8 14.4
Return on capital employed % 19.0 20.8
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster



To see how CARE RATING has performed over the last 5 years, please visit here.

CARE RATING Share Price Performance

Over the last one year, CARE RATING share price has moved up from Rs 681.7 to Rs 1,094.0, registering a gain of Rs 412.4 or around 60.5%.

Overall, the S&P BSE SENSEX is up 22.2% over the year.

(To know more, check out historical annual results for CARE RATING and quarterly results for CARE RATING)

Annual Report FAQs

What is the current share price of CARE RATING?

CARE RATING currently trades at Rs 1,386.5 per share. You can check out the latest share price performance of CARE RATING here...

What was the revenue of CARE RATING in FY24? How does it compare to earlier years?

The revenues of CARE RATING stood at Rs 3,784 m in FY24, which was up 19.4% compared to Rs 3,169 m reported in FY23.

CARE RATING's revenue has grown from Rs 2,751 m in FY20 to Rs 3,784 m in FY24.

Over the past 5 years, the revenue of CARE RATING has grown at a CAGR of 8.3%.

What was the net profit of CARE RATING in FY24? How does it compare to earlier years?

The net profit of CARE RATING stood at Rs 1,026 m in FY24, which was up 20.0% compared to Rs 855 m reported in FY23.

This compares to a net profit of Rs 768 m in FY22 and a net profit of Rs 910 m in FY21.

Over the past 5 years, CARE RATING net profit has grown at a CAGR of 5.3%.

What does the cash flow statement of CARE RATING reveal?

The cash flow statement is the financial statement that presents the cash inflows and outflows of a company during a given period of time.

This statement is one of the most useful tools for judging a company's liquidity position. The ratios and parameters in this statement helps test a company's financial health.

The cash flow statement of CARE RATING reveals:

  • Cash flow from operations increased in FY24 and stood at Rs 909 m as compared to Rs 822 m in FY23.
  • Cash flow from investments decreased in FY24 and stood at Rs -391 m as compared to Rs 129 m in FY23.
  • Cash flow from financial activity increased in FY24 and stood at Rs -630 m as compared to Rs -633 m in FY23.

Here's the cash flow statement of CARE RATING for the past 5 years.

(Rs m)FY20FY21FY22FY23FY24
From Operations674862680822909
From Investments267-377-273129-391
From Financial Activity-1,070-434-351-633-630
Net Cashflow-1285155318-111

What does the Key Ratio analysis of CARE RATING reveal?

Be it the company's profitability, operations effectiveness or utilization of funds, ratio analysis is an important tool which helps in making investment decisions.

The ratio/financial analysis of CARE RATING reveals:

  • Operating profit margins witnessed a fall and stood at 33.8% in FY24 as against 35.6% in FY23.
  • Net profit margins grew from 30.6% in FY23 to 30.9% in FY24.
  • Debt to Equity ratio for FY24 stood at 0.0 as compared to 0.0 in FY23.

Here's the ratio/financial analysis of CARE RATING for the past 5 years.

 FY20FY21FY22FY23FY24
Operating Profit Margin (%)33.438.532.135.633.8
Net Profit Margin (%)34.336.631.030.630.9
Debt to Equity Ratio (x)0.00.00.00.00.0

Equitymaster requests your view! Post a comment on "CARE RATING 2023-24 Annual Report Analysis". Click here!